Results
Filtros
RDC-327 and Cannabis Research: Lawyer Explains Proposal to Extend Deadline for Clinical Studies
On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa
CFF advocates for magistral manipulation amid changes in Cannabis regulation
Entity reinforces that personalized preparations are essential when industrialized products do not meet clinical needs
Cannabis cultivation and regulatory review take center stage in the 2026–2027 Regulatory Agenda
Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis
Proposal to restrict Cannabis importation (RDC 660) sparks reaction in the market
Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization
Request Authorization to Import Cannabis-Derived Products
01/01/2024Follow the instructions to initiate the import process through RDC 660
Evolution and Challenges of Veterinary Medicine in Brazil in the Prescription of Medicinal Cannabis
Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products
Ways to Access Cannabis Products in Brazil
01/18/2023Understand the step-by-step process to acquire plant derivatives for medicinal purposes
“It is important that the compounding pharmacy has access to all cannabis inputs" argues Marco Fiaschetti, from Anfarmag
With the revision of RDC 327/2019, compounding pharmacies gain space in the discussion on medicinal cannabis
Is Brazil hindering the future of cannabis? Experts discuss the delay and pathways to unlock the country's potential
In Deusa Cast #46, experts like Jaime Ozi analyze the obstacles preventing Brazil from advancing in cannabis regulation and highlight the impact of lack of research, medical education, and access
The quality of cannabis products produced by the industry in Brazil
How the pharmaceutical industry ensures quality and safety in cannabis-based products sold in Brazil
From Cultivation to Patient: Behind the Scenes of Safety and Quality of Cannabis-Based Products in Brazil
10/13/2026The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment
State of SP and Campinas must provide cannabidiol to patient with fibromyalgia, headache, and anxiety
Unanimous decision from the 3rd Public Law Chamber benefits a woman, the rapporteur cites STJ criteria
Traveling with Medical Cannabis at the End of the Year: What Patients Need to Know to Avoid Issues
Planning to travel at the end of the year and using medical cannabis? Learn about the required documents, how to transport the medication, and what precautions to take in Brazil and abroad
Full Spectrum Cannabidiol: Why the Complete Cannabis Formulation Improves Chronic Pain Treatment
Learn how full spectrum cannabidiol enhances the therapeutic effects of medicinal cannabis, reduces doses, improves tolerance, and expands outcomes in chronic pain treatment
STJ highlights completion of most stages to regulate the cultivation of medicinal cannabis
The new deadline extends the time for the government to finalize the regulation of cannabis cultivation for the production of medicines in the country
Today: Cannabis Connection brings together experts in SP starting at 2:30 pm
São Paulo hosts, on Thursday (06), the main meeting point for the Medicinal and Industrial Cannabis industry in Latin America
Today: STJ judges Government deadline and creation of 'Regulatory Sandbox' for cannabis
First Section's trial will take place on Thursday (06); decision impacts cannabis regulation in the country
Third sector leads number of proposals submitted in the Alesp Cannabis Front Edict
Public universities and Municipalities close the top three; $1.25 million will be allocated to medicinal cannabis and industrial hemp projects
Third sector leads number of proposals submitted in the Alesp Cannabis Front Edict
Public universities and Municipalities close the top three; R$ 1.25 million will be allocated to medicinal cannabis and industrial hemp projects
Cannabis Mosaic: States with Own Laws May Lead the Way in Regulation
While the federal government delays the delivery of rules for cultivation, states are advancing with their own legislation and building a framework that could anticipate the direction of national regulation